Could a common diabetes pill protect the brain after a stroke?

This study tests whether canagliflozin, a diabetes drug, can reduce dangerous brain swelling and bleeding in people who have had a severe stroke and are receiving clot-removal therapy. About 150 adults will be randomly assigned to take the drug for 14 days or receive standard care alone. The goal is to see if this medication can improve recovery and reduce complications after stroke treatment.